The Link between Type III Reg and STAT3-Associated Cytokines in Inflamed Colonic Tissues

Xu, Xin; Fukui, Hirokazu; Ran, Ying; Wang, Xuan; Inoue, Yoshihito; Ebisudani, Nobuhiko; Nishimura, Heihachiro; Tomita, Toshihiko; Oshima, Tadayuki; Watari, Jiro; Kiyama, Hiroshi; Miwa, Hiroto

doi:https://doi.org/10.1155/2019/7859460

Mediators of Inflammation

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusions Data Availability Conflicts of Interest Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2019 | Article ID 7859460 | https://doi.org/10.1155/2019/7859460

The Link between Type III Reg and STAT3-Associated Cytokines in Inflamed Colonic Tissues

Xin Xu,^1,2Hirokazu Fukui ,¹Ying Ran,^1,2Xuan Wang,^1,2Yoshihito Inoue,¹Nobuhiko Ebisudani,¹Heihachiro Nishimura,¹Toshihiko Tomita,¹Tadayuki Oshima,¹Jiro Watari,¹Hiroshi Kiyama,³and Hiroto Miwa¹

Academic Editor: Daniela Novick

Received28 May 2019

Revised10 Sept 2019

Accepted25 Sept 2019

Published06 Nov 2019

Abstract

Reg (regenerating gene) family proteins are known to be overexpressed in gastrointestinal (GI) tissues under conditions of inflammation. However, the pathophysiological significance of Reg family protein overexpression and its regulation is still unclear. In the present study, we investigated the profile of Reg family gene expression in a colitis model and focused on the regulation of Reg IIIβ and IIIγ, which are overexpressed in inflamed colonic mucosa. C57BL/6 mice were administered 2% dextran sulfate sodium (DSS) in drinking water for five days, and their colonic tissues were investigated histopathologically at interval for up to 12 weeks. Gene expression of the Reg family and cytokines (IL-6, IL-17, and IL-22) was evaluated by real-time RT-PCR, and Reg IIIβ/γ expression was examined by immunohistochemistry. The effects of cytokines on STAT3 phosphorylation and HIP/PAP (type III REG) expression in Caco2 and HCT116 cells were examined by Western blot analysis. Among Reg family genes, Reg IIIβ and IIIγ were alternatively overexpressed in the colonic tissues of mice with DSS-induced colitis. The expression of STAT3-associated cytokines (IL-6, IL-17, and IL-22) was also significantly increased in those tissues, being significantly correlated with that of Reg IIIβ/γ. STAT3 phosphorylation and HIP/PAP expression were significantly enhanced in Caco2 cells upon stimulation with IL-6, IL-17, and IL-22. In HCT116 cells, those enhancements were also observed by IL-6 and IL-22 stimulations but not IL-17. The link between type III Reg and STAT3-associated cytokines appears to play a pivotal role in the pathophysiology of DSS-induced colitis.

1. Introduction

The regenerating gene (Reg) was first discovered in regenerating rat pancreatic islets [1], and since then, many Reg-related genes constituting a multigene family (types I–IV) have been isolated [2–5]. We and others have previously reported that Reg family proteins are involved in the pathophysiology of gastrointestinal (GI) inflammatory diseases such as H. pylori-associated gastritis [6], NSAID-induced GI injuries [7], and inflammatory bowel disease [8–10]. In terms of function, we have clarified that Reg Iα protein plays a role in tissue regeneration as mitogenic and/or antiapoptotic factor [11, 12], and other Reg family proteins likely have similar roles in inflamed tissues [13–16]. These findings strongly suggest that Reg family proteins are involved in the regeneration of GI tissues that have been injured by inflammation. However, it is still unclear how these proteins with similar function act cooperatively and/or independently in specific GI inflammatory diseases and how Reg family proteins are regulated in such diseases.

Ulcerative colitis is a chronic inflammatory disease characterized by diffuse mucosal inflammation in the colorectum although its pathophysiology has remained largely unclear. Interestingly, comprehensive analyses by several groups have suggested that the expression of Reg family genes is distinctly upregulated in the colonic epithelium in UC [17–19], implying a role in the pathophysiology of UC. Indeed, among Reg family proteins, it has been suggested that type III Reg might have a potentially protective effect against colitis [20, 21] and that its effects may be modulated by interaction between type III Reg proteins and the mucosal immune system [22, 23]. These findings suggest that the molecules associated with the mucosal immune system play a pivotal role in the regulation of Reg family protein induction in inflamed colonic tissues, although the mechanism is not yet fully clear. Here, we investigated the profiles of Reg family gene expression in a dextran sulfate sodium- (DSS-) induced colitis model, focusing on the regulation of type III Reg in the inflamed colonic tissues.

2. Materials and Methods

2.1. Animal Model

C57BL/6 mice (eight-week-old females) were used in this study. All the mice were maintained under specific pathogen-free conditions and allowed free access to food and water. The mice were administered 2% dextran sulfate sodium (DSS; molecular weight 36,000–50,000; ICN Biomedicals Inc., Aorano, OH, USA) in drinking water for five days as previously described [24]. Their colonic tissues were removed at various time points, cut open along the longitudinal axis, and fixed in neutral aqueous phosphate-buffered 10% formalin for histological examinations. This animal experiment was performed with the approval of the Animal Use and Care Committee at Hyogo College of Medicine.

2.2. Histological Evaluation

Histological evaluation was performed using the tissue sections that were cut perpendicularly to the surface and stained with hematoxylin and eosin. The degree of inflammatory cell infiltration in the colon was scored on a scale of 0 to 3 as follows [24]: 0, normal; 1, inflammatory cell infiltration into the mucosal layer; 2, up to the submucosal layer; and 3, beyond the submucosal layer. The depth of tissue damage in the colon was scored on a scale of 0 to 4 as follows: 0, none; 1, mucosa; 2, submucosa; 3, muscularis propria; and 4, serosa [7]. The histological damage score was evaluated as the sum of those scores for all of the slides of each mouse, and the results were averaged.

2.3. Immunohistochemistry

Immunohistochemical staining for Reg IIIβ and Reg IIIγ was performed with an Envision Kit (Dako, Kyoto, Japan) as previously described [25], using anti-Reg IIIβ antibody (dilution; 1 : 500; gift by Prof. Kiyama) and anti-Reg IIIγ antibody (dilution; 1 : 500; gift by Prof. Kiyama). The immunohistochemical reliability had been confirmed in the nerve system and the intestine in the previous works [26–28]. In brief, the rehydrated sections were treated by microwave heating for 20 min in 1x Dako REAL Target Retrieval Solution (Dako Denmark, Glostrup, Denmark) and then preincubated with 0.3% H₂O₂ in methanol for 20 min at room temperature to quench endogenous peroxidase activity. Then, the sections were incubated with primary antibodies for 60 min at room temperature, washed in PBS, and incubated with horseradish peroxidase-conjugated secondary antibody for 30 min. The slides were visualized by 3,3-diaminobenzidine tetrahydrochloride with 0.05% H₂O₂ for 3 min and then counterstained with Mayer’s hematoxylin.

2.4. Cell Culture and Reagents

Recombinant human IL-6, IL-17, and IL-22 were purchased from R&D Systems (Minneapolis, MN, USA). Anti-human HIP/PAP (REG type III) antibody was purchased from Novus Biologicals (Littleton, CO, USA). Anti-STAT3 and anti-phospho-specific STAT3 (Tyr705) antibodies were purchased from Cell Signaling Technology (Beverly, MA, USA). Anti-β-actin antibody was purchased from Sigma.

Human intestinal epithelial cell line Caco2 and HCT116 cells were cultured in RPMI 1640 medium (Invitrogen, Carlsbad, CA, USA) with 10% fetal bovine serum (Biowest, Nuaillé, France) in a humidified incubator at 37°C with an atmosphere of 5% CO₂. As mentioned in figure legends, the cells were treated with recombinant cytokines at indicated concentrations, respectively.

2.5. Western Blot Analysis

Western blot analyses were performed using each primary antibody as previously described [29]. After treatment with or without reagents, cells were lysed in protein extraction buffer. Protein extract (20 μg) was fractionated by SDS-polyacrylamide gel electrophoresis and transferred to a polyvinylidene difluoride membrane. The membrane was incubated with a primary antibody and then with a peroxidase-conjugated secondary antibody. Proteins were detected using an enhanced chemiluminescence system (Amersham Biosciences, Buckinghamshire, UK). ImageJ software (NIH) was used for quantification of intensities of target bands. The staining intensity of β-actin was set as the internal control. The value in the individual test was expressed as fold of target protein/β-actin in the standard group.

2.6. Real-Time RT-PCR

Total RNA was isolated from GI tissues and Caco2 cells with TRIzol reagent (Invitrogen, Carlsbad, CA). Four micrograms of total RNA was reverse-transcribed using oligo-dT primer (Applied Biosystems, Branchburg, NJ), and real-time RT-PCR was performed using 7900H Fast Real-Time RT-PCR System (Applied Biosystems) as previously reported [30]. The set of primers used were shown in Table 1. Real-time RT-PCR assays were carried out with 200 ng of RNA equivalent cDNA, SYBR Green Master Mix (Applied Biosystems), and 500 nmol/l gene-specific primers. The PCR cycling conditions were 95°C for 15 s and 60°C for 60 s. The intensity of the fluorescent dye was determined, and the expression levels of target genes mRNA were normalized to those of GAPDH mRNA.

2.7. Statistical Analysis

All values were expressed as the . Significance of differences between two animal groups was analyzed by Mann–Whitney -test. Correlations between two parameters were assessed by linear regression analysis. Differences were considered to be significant at .

3. Results

3.1. Histological Features of DSS-Induced Colitis in Mice

DSS treatment induced strong infiltration of inflammatory cells into the colonic mucosa and/or muscular layer (Figure 1(a)). In the acute phase, severe mucosal damage or ulcer formation was observed in some of the experimental mice. The severity of inflammatory cell infiltration peaked at 2 weeks after DSS induction (Figure 1(b)). Thereafter, in the resolution phase, the inflammatory cell infiltration gradually declined but persisted at a very weak level (Figure 1(b)).

(a)

(b)

3.2. Changes in Reg Family Gene Expression in Colonic Tissue of Mice with DSS-Induced Colitis

We examined changes in Reg family gene expression in the colonic tissue of mice at various time points after the induction of DSS colitis (Figure 2). The expression of mRNA for Reg IIIβ and Reg IIIγ was markedly upregulated in mice with DSS treatment relative to controls. The expression of Reg IIIβ peaked at 1 week after DSS treatment and gradually decreased but remained significantly elevated between 1 and 8 weeks after DSS treatment. The expression of Reg IIIγ also peaked at 2 weeks after DSS treatment and declined gradually thereafter. However, Reg IIIγ expression was sustained at a significantly high level until the end of the experimental period (Figure 2).

On the other hand, the levels of expression of mRNAs for Reg I, Reg II, Reg IIIα, and Reg IIIδ were not altered by the DSS treatment during the experimental period. As reported previously [7], the expression of Reg IV was basically high in the colon relative to that of the other Reg family genes. However, under the present experimental conditions, the expression of Reg IV mRNA did not increase as dramatically as that of Reg IIIβ or IIIγ (Figure 2).

3.3. Relationship between Histology and Reg IIIβ/γ Expression in DSS-Induced Colitis

As shown in Figure 3(a), the expression of Reg IIIβ and IIIγ proteins was upregulated in the colonic epithelial cells of mice after DSS treatment relative to the untreated controls.

(a)

(b)

We then investigated the correlation between Reg IIIβ/γ expression and histological damage score (Figure 3(b)). The expression of both Reg IIIβ and Reg IIIγ showed a significantly strong correlation with the histological damage score, suggesting a link with colonic inflammatory injury.

3.4. Expression of Cytokines in Colonic Tissue of Mice with DSS-Induced Colitis

Previous studies of Reg I or Reg type III gene expression have suggested that IL-6 and Th17-producing cytokines (IL-17 and/or IL-22) may be key regulators of Reg family genes under inflammatory condition [8, 31–34]. Therefore, we investigated the expression of those cytokines in mice with DSS-induced colitis in relation to Reg IIIβ/γ expression. The expression of IL-6 and IL-17 mRNA was significantly elevated in tissues of mice with colitis from 1 to 4 weeks after DSS treatment (Figure 4(a)). IL-22 expression was significantly elevated at 2 weeks after DSS treatment. Linear regression analysis showed that Reg IIIβ/γ expression was positively correlated with IL-6, IL-17, and IL-22 expressions in the inflamed colonic tissues (Figure 4(b)).

(a)

(b)

3.5. Induction of Human HIP/PAP by Cytokine Stimulation in Caco2 and HCT116 Cells

Human HIP/PAP (hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein) and REG III are classified into type III REG gene and have 85% homology in amino acids sequences [35]. In this study, we examined the effect of cytokines (IL-6, IL-17, and IL-22) on the expression of p-STAT3 and human HIP/PAP in Caco2 cells in vitro. HIP/PAP mRNA expression was dose-dependently enhanced by IL-6, IL-17, and IL-22, respectively (Figure 5(a)). In accordance with the results of real-time RT-PCR analyses, the expression of HIP/PAP protein was significantly enhanced by stimulation with IL-6, IL-17, and IL-22 (Figure 5(b)). Moreover, we confirmed that the enhancement of HIP/PAP expression by these cytokines was associated with activated phosphorylation of STAT3 (Figure 5(c)).

(a)

(b)

(c)

Figure 5

Effect of cytokines on the expression of human HIP/PAP in Caco2 cells. (a) Dose-dependent effect of cytokines (IL-6, IL-17, and IL-22) on HIP/PAP mRNA expression in Caco2 cells. Caco2 cells () were cultured in 6-well plates for 24 h and then treated with cytokines (IL-6, IL-17, and IL-22) at the indicated concentrations for 24 h. (b) Dose-dependent effects of cytokines (IL-6, IL-17A, and IL-22) on HIP/PAP protein expression in Caco2 cells. (c) Dose-dependent effects of cytokines (IL-6, IL-17, and IL-22) on phosphorylation of STAT3 in Caco2 cells. Caco2 cells () were cultured in 6-well plates for 24 h and then treated with cytokines (IL-6, IL-17, and IL-22) at the indicated concentrations for 30 min. Results are expressed as the . Significantly greater than in controls at the same time point: and .

The same experiment was carried out using another colon cancer cells (HCT116) (Figure 6). IL-6 and IL-22 stimulations enhanced STAT3 phosphorylation and HIP/PAP expression (Figure 6(a)). On the other hand, IL-17 treatment showed no effects on STAT3 phosphorylation nor HIP/PAP expression in HCT116 cell. As for REG III (Figure 6(b)), its gene expression level was significantly enhanced by IL-6 and IL-22 stimulations. Similar tendency was found in HCT116 cell by IL-17 stimulation () but not statistically significant.

(a)

(b)

Figure 6

(a) Effect of cytokines on STAT3 phosphorylation and human HIP/PAP expression in HCT116 cells. HCT116 cells () were cultured in 6-well plates for 24 h and then treated with cytokines (IL-6, IL-17, and IL-22) at 100 ng/ml for 24 h and 30 min to examine HIP/PAP expression and STAT3 phosphorylation, respectively. (b) Effect of cytokines on REG III expression. HCT116 cells were stimulated by cytokines at 100 ng/ml for 24 h (). Results are expressed as the . Significantly greater than in controls: .

4. Discussion

It has been reported that most genes in the human REG family (REG I, III, and IV) are overexpressed in inflammatory bowel diseases [36]. In the present study, we investigated the expression profile of Reg family genes in DSS-induced colitis as a model of UC. In mice, seven Reg family genes have been isolated [2–5, 37], and here, we clarified that Reg IIIβ/γ, but not other members of the family, were specifically overexpressed in inflamed colonic tissues. Although it is unclear why the expression of other REG family genes was not changed in mouse DSS-induced colitis, unlike the situation in human inflammatory bowel diseases, the difference in species may be partly responsible. The Reg family gene profile (i.e., expression intensity and distribution) in the human GI tract has not been investigated comprehensively; however, the expression of REG Iα, Iβ, III, and IV proteins is detectable in normal colonic epithelial cells by immunohistochemistry [9, 19, 36, 38]. We have previously demonstrated that each gene in the Reg family shows predominance in expressional intensity and distribution in the mouse GI tract [7]. In the mouse colon, the expression of Reg IV is the strongest, whereas that of Reg I, Reg IIIα/β/γ/δ is much weaker and Reg II is almost undetectable [7]. Therefore, we had expected that Reg IV might be predominantly overexpressed in colitis. However, Reg IIIβ/γ, whose expression is the strongest in the small intestine under normal conditions, was specifically overexpressed in DSS-induced colitis. Thus, although REG family genes may be commonly upregulated in human inflamed GI tissues, their expression appears to be alternatively upregulated, at least in this experimental colitis model.

Here, we demonstrated that Reg IIIβ and IIIγ are expressed in colonic epithelial cells and that their gene expression is significantly correlated with the degree of histological damage to colonic tissue, similar to the situation for REG Iα in human UC [8]. Studies of the mechanism responsible for regulating the expression of Reg family genes have shown that cytokines and growth factors play a critical role in this respect [9, 31, 32, 39]. This seems to be reasonable, as cytokines and growth factors are produced abundantly in damaged GI tissues. However, little information is available on the transcriptional factors responsible for the promoter activities of Reg family genes. In this connection, we have previously shown that cytokine-associated STAT3 can bind to, and activate, the promoter of the REG Iα gene in gastric and colon cancer cells [31, 39]. Other studies have clarified the presence of cytokine (IL-6 and IL-22)-responsive elements in the promoter regions of REG Iα and Iβ and HIP/PAP in pancreatic or colon cancer cells [32, 40], although it remained unclear whether STAT3 and/or other transcriptional factors actually bind to these elements. However, the present findings at least suggest that STAT3-associated cytokines play a pivotal role in the induction of REG I and type III REG expression. Indeed, it was noteworthy that STAT3-associated cytokines (IL-6, IL-22, and IL-17) were upregulated in the colonic tissues of mice with DSS-induced inflammation and that their expression was significantly correlated with that of both Reg IIIβ and IIIγ. Furthermore, we reconfirmed that those STAT3-associated cytokines stimulate the production of HIP/PAP protein through activation of STAT3 phosphorylation in vitro. However, we have to describe that detailed analyses of HIP/PAP gene promoter are still remained unclear in further studies.

What is the significance of Reg IIIβ/γ expression in DSS-induced colitis? Similar to REG I, II, and IV [9, 11–13, 16], type III REG proteins are known to act as mitogenic and/or antiapoptotic factors [14, 15], implying a role in the prevention of tissue damage and/or the regeneration of injured tissues. Ogawa et al. have demonstrated that not only DSS-induced colitis but also the presence of commensal gut microbiota is important for the induction of Reg IIIβ/γ expression in the colon [10]. Although the data are not conclusive, it is interesting to consider whether bacteria affect Reg IIIβ/γ expression in GI epithelial cells directly or indirectly via activation of cytokine-producing immune cells. Reg family proteins have a characteristic C-type lectin structure [41], and much attention has recently been paid to the possibility that these proteins may act as antimicrobial factors in the GI tract and skin [22, 23, 42, 43]. Together, the data strongly suggest that overexpression of Reg IIIβ/γ in colonic tissues of mice with DSS-induced colitis represents a protective and/or reparative mucosal defense mechanism.

In summary, among genes of the Reg family, Reg IIIβ and IIIγ were alternatively overexpressed in the colonic epithelial cells of mice with DSS-induced colitis. In this experimental model, the expression of STAT3-associated cytokines such as IL-6, IL-17, and IL-22 was significantly increased, and these cytokines clearly upregulated HIP/PAP expression via activation of STAT-3 phosphorylation in vitro. Furthermore, we showed that the in vivo expression of Reg IIIβ/γ was significantly correlated with that of STAT3-associated cytokines in this model of DSS-induced colitis. These findings suggest that STAT3-associated cytokine/type III Reg axis plays a pivotal role in the pathophysiology of not only the acute phase but also the healing process of colitis. Although the accumulated data strongly suggest that type III Reg proteins have a protective role against colitis, future studies will need to clarify the mechanism by which these proteins operate in colitis.

5. Conclusions

Type III Reg protein linked to STAT3-associated cytokine stimulation plays a pivotal role in the pathophysiology of DSS-induced colitis in mice.

Data Availability

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Conflicts of Interest

The authors declare no conflicts of interest.

Acknowledgments

We thank Chiyomi Ito and Mayumi Yamada (Hyogo College of Medicine) for their technical assistance. This work was supported in part by Grants-in-Aid for Scientific Research 17K09363 from the Ministry of Education, Culture, Sports, Science and Technology, Japan.

References

K. Terazono, H. Yamamoto, S. Takasawa et al., “A novel gene activated in regenerating islets,” The Journal of Biological Chemistry, vol. 263, no. 5, pp. 2111–2114, 1988.
View at: Google Scholar
M. Unno, H. Yonekura, K. Nakagawara et al., “Structure, chromosomal localization, and expression of mouse reg genes, reg I and reg II. A novel type of reg gene, reg II, exists in the mouse genome,” The Journal of Biological Chemistry, vol. 268, no. 21, pp. 15974–15982, 1993.
View at: Google Scholar
J. C. Hartupee, H. Zhang, M. F. Bonaldo, M. B. Soares, and B. K. Dieckgraefe, “Isolation and characterization of a cDNA encoding a novel member of the human regenerating protein family: Reg IV,” Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, vol. 1518, no. 3, pp. 287–293, 2001.
View at: Publisher Site | Google Scholar
S. Takasawa, “Regenerating gene (REG) product and its potential clinical usage,” Expert Opinion on Therapeutic Targets, vol. 20, no. 5, pp. 541–550, 2016.
View at: Publisher Site | Google Scholar
T. Fujimura, T. Fujimoto, A. Itaya-Hironaka et al., “Significance of interleukin-6/STAT pathway for the gene expression of REG Iα, a new autoantigen in Sjögren’s syndrome patients, in salivary duct epithelial cells,” Clinical Reviews in Allergy and Immunology, vol. 52, no. 3, pp. 351–363, 2017.
View at: Publisher Site | Google Scholar
H. Fukui, F. Franceschi, R. L. Penland et al., “Effects of Helicobacter pylori infection on the link between regenerating gene expression and serum gastrin levels in Mongolian gerbils,” Laboratory Investigation, vol. 83, no. 12, pp. 1777–1786, 2003.
View at: Publisher Site | Google Scholar
C. Sun, H. Fukui, K. Hara et al., “Expression of Reg family genes in the gastrointestinal tract of mice treated with indomethacin,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 308, no. 9, pp. G736–G744, 2015.
View at: Publisher Site | Google Scholar
A. Sekikawa, H. Fukui, S. Fujii et al., “Possible role of REG I protein in ulcerative colitis and colitic cancer,” Gut, vol. 54, no. 10, pp. 1437–1444, 2005.
View at: Publisher Site | Google Scholar
A. Nanakin, H. Fukui, S. Fujii et al., “Expression of the REG IV gene in ulcerative colitis,” Laboratory Investigation, vol. 87, no. 3, pp. 304–314, 2007.
View at: Publisher Site | Google Scholar
H. Ogawa, K. Fukushima, H. Naito et al., “Increased expression of HIP/PAP and regenerating gene III in human inflammatory bowel disease and a murine bacterial reconstitution model,” Inflammatory Bowel Diseases, vol. 9, no. 3, pp. 162–170, 2003.
View at: Publisher Site | Google Scholar
H. Fukui, Y. Kinoshita, T. Maekawa et al., “Regenerating gene protein may mediate gastric mucosal proliferation induced by hypergastrinemia in rats,” Gastroenterology, vol. 115, no. 6, pp. 1483–1493, 1998.
View at: Publisher Site | Google Scholar
A. Sekikawa, H. Fukui, S. Fujii et al., “REG Iα protein may function as a trophic and/or anti-apoptotic factor in the development of gastric cancer,” Gastroenterology, vol. 128, no. 3, pp. 642–653, 2005.
View at: Publisher Site | Google Scholar
F. J. Livesey, J. A. O'Brien, M. Li, A. G. Smith, L. J. Murphy, and S. P. Hunt, “A Schwann cell mitogen accompanying regeneration of motor neurons,” Nature, vol. 390, no. 6660, pp. 614–618, 1997.
View at: Publisher Site | Google Scholar
X. Liu, J. Wang, H. Wang et al., “REG3A accelerates pancreatic cancer cell growth under IL-6-associated inflammatory condition: involvement of a REG3A-JAK2/STAT3 positive feedback loop,” Cancer Letters, vol. 362, no. 1, pp. 45–60, 2015.
View at: Publisher Site | Google Scholar
H. T. Lieu, F. Batteux, M. T. Simon et al., “HIP/PAP accelerates liver regeneration and protects against acetaminophen injury in mice,” Hepatology, vol. 42, no. 3, pp. 618–626, 2005.
View at: Publisher Site | Google Scholar
K. S. Bishnupuri, Q. Luo, S. K. Sainathan et al., “Reg IV regulates normal intestinal and colorectal cancer cell susceptibility to radiation-induced apoptosis,” Gastroenterology, vol. 138, pp. 616–626.e2, 2010.
View at: Publisher Site | Google Scholar
B. K. Dieckgraefe, W. F. Stenson, J. R. Korzenik, P. E. Swanson, and C. A. Harrington, “Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays,” Physiological Genomics, vol. 4, no. 1, pp. 1–11, 2000.
View at: Publisher Site | Google Scholar
I. C. Lawrance, C. Fiocchi, and S. Chakravarti, “Ulcerative colitis and Crohn’s disease: distinctive gene expression profiles and novel susceptibility candidate genes,” Human Molecular Genetics, vol. 10, no. 5, pp. 445–456, 2001.
View at: Publisher Site | Google Scholar
A. van Beelen Granlund, A. E. Østvik, Ø. Brenna, S. H. Torp, B. I. Gustafsson, and A. K. Sandvik, “REG gene expression in inflamed and healthy colon mucosa explored by in situ hybridisation,” Cell and Tissue Research, vol. 352, no. 3, pp. 639–646, 2013.
View at: Publisher Site | Google Scholar
M. Gironella, J. L. Iovanna, M. Sans et al., “Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease,” Gut, vol. 54, no. 9, pp. 1244–1253, 2005.
View at: Publisher Site | Google Scholar
Y. Lv, X. Yang, Y. Huo et al., “Adenovirus-mediated hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein suppresses dextran sulfate sodium-induced acute ulcerative colitis in rats,” Inflammatory Bowel Diseases, vol. 18, no. 10, pp. 1950–1960, 2012.
View at: Publisher Site | Google Scholar
S. Vaishnava, M. Yamamoto, K. M. Severson et al., “The antibacterial lectin RegIII gamma promotes the spatial segregation of microbiota and host in the intestine,” Science, vol. 334, no. 6053, pp. 255–258, 2011.
View at: Publisher Site | Google Scholar
M. Darnaud, A. Dos Santos, P. Gonzalez et al., “Enteric delivery of regenerating family member 3 alpha alters the intestinal microbiota and controls inflammation in mice with colitis,” Gastroenterology, vol. 154, no. 4, pp. 1009–1023.e14, 2018.
View at: Publisher Site | Google Scholar
M. Kodani, H. Fukui, T. Tomita, T. Oshima, J. Watari, and H. Miwa, “Association between gastrointestinal motility and macrophage/mast cell distribution in mice during the healing stage after DSS-induced colitis,” Molecular Medicine Reports, vol. 17, no. 6, pp. 8167–8172, 2018.
View at: Publisher Site | Google Scholar
H. Yamagishi, H. Fukui, A. Sekikawa et al., “Expression profile of REG family proteins REG Ialpha and REG IV in advanced gastric cancer: comparison with mucin phenotype and prognostic markers,” Modern Pathology, vol. 22, no. 7, pp. 906–913, 2009.
View at: Publisher Site | Google Scholar
C. M. Hodin, K. Lenaerts, J. Grootjans et al., “Starvation compromises Paneth cells,” The American Journal of Pathology, vol. 179, no. 6, pp. 2885–2893, 2011.
View at: Publisher Site | Google Scholar
S. Matsumoto, H. Konishi, R. Maeda, S. Kiryu-Seo, and H. Kiyama, “Expression analysis of the regenerating gene (Reg) family members Reg-IIIβ and Reg-IIIγ in the mouse during development,” The Journal of Comparative Neurology, vol. 520, no. 3, pp. 479–494, 2012.
View at: Publisher Site | Google Scholar
H. Konishi, S. Matsumoto, K. Namikawa, and H. Kiyama, “N-terminal cleaved pancreatitis-associated protein-III (PAP-III) serves as a scaffold for neurites and promotes neurite outgrowth,” The Journal of Biological Chemistry, vol. 288, no. 15, pp. 10205–10213, 2013.
View at: Publisher Site | Google Scholar
H. Fukui, X. Zhang, C. Sun et al., “IL-22 produced by cancer-associated fibroblasts promotes gastric cancer cell invasion via STAT3 and ERK signaling,” British Journal of Cancer, vol. 111, no. 4, pp. 763–771, 2014.
View at: Publisher Site | Google Scholar
Y. Kitayama, H. Fukui, K. Hara et al., “Role of regenerating gene I in claudin expression and barrier function in the small intestine,” Translational Research, vol. 173, pp. 92–100, 2016.
View at: Publisher Site | Google Scholar
A. Sekikawa, H. Fukui, K. Suzuki et al., “Involvement of the IL-22/REG I alpha axis in ulcerative colitis,” Laboratory Investigation, vol. 90, no. 3, pp. 496–505, 2010.
View at: Publisher Site | Google Scholar
H. Rechreche, G. Montalto, G. V. Mallo et al., “pap, reg Ialpha and reg Ibeta mRNAs are concomitantly up-regulated during human colorectal carcinogenesis,” International Journal of Cancer, vol. 81, no. 5, pp. 688–694, 1999.
View at: Publisher Site | Google Scholar
Y. Zheng, P. A. Valdez, D. M. Danilenko et al., “Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens,” Nature Medicine, vol. 14, no. 3, pp. 282–289, 2008.
View at: Publisher Site | Google Scholar
K. Eyerich, V. Dimartino, and A. Cavani, “IL-17 and IL-22 in immunity: driving protection and pathology,” European Journal of Immunology, vol. 47, no. 4, pp. 607–614, 2017.
View at: Publisher Site | Google Scholar
K. Nata, Y. Liu, L. Xu et al., “Molecular cloning, expression and chromosomal localization of a novel human REG family gene, REG III,” Gene, vol. 340, no. 1, pp. 161–170, 2004.
View at: Publisher Site | Google Scholar
A. Van Beelen Granlund, V. Beisvag, S. H. Torp et al., “Activation of REG family proteins in colitis,” Scandinavian Journal of Gastroenterology, vol. 46, no. 11, pp. 1316–1323, 2011.
View at: Publisher Site | Google Scholar
Y. Kinoshita, S. Ishihara, Y. Kadowaki, H. Fukui, and T. Chiba, “Reg protein is a unique growth factor of gastric mucosal cells,” Journal of Gastroenterology, vol. 39, no. 6, pp. 507–513, 2004.
View at: Publisher Site | Google Scholar
H. Tanaka, H. Fukui, S. Fujii et al., “Immunohistochemical analysis of REG Iα expression in ulcerative colitis-associated neoplastic lesions,” Digestion, vol. 83, no. 3, pp. 204–209, 2011.
View at: Publisher Site | Google Scholar
A. Sekikawa, H. Fukui, S. Fujii et al., “REG Iα protein mediates an anti-apoptotic effect of STAT3 signaling in gastric cancer cells,” Carcinogenesis, vol. 29, no. 1, pp. 76–83, 2008.
View at: Publisher Site | Google Scholar
C. Tsuchida, S. Sakuramoto-Tsuchida, M. Taked et al., “Expression of REG family genes in human inflammatory bowel diseases and its regulation,” Biochemistry and Biophysics Reports, vol. 12, pp. 198–205, 2017.
View at: Publisher Site | Google Scholar
L. Patthy, “Homology of human pancreatic stone protein with animal lectins,” The Biochemical Journal, vol. 253, no. 1, pp. 309–311, 1988.
View at: Publisher Site | Google Scholar
H. L. Cash, C. V. Whitham, C. L. Behrendt, and L. V. Hooper, “Symbiotic bacteria direct expression of an intestinal bactericidal lectin,” Science, vol. 313, no. 5790, pp. 1126–1130, 2006.
View at: Publisher Site | Google Scholar
T. Miki, O. Holst, and W. D. Hardt, “The bactericidal activity of the C-type lectin RegIIIβ against Gram-negative bacteria involves binding to lipid A,” The Journal of Biological Chemistry, vol. 287, no. 41, pp. 34844–34855, 2012.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2019 Xin Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

814

Downloads

984

Citations